Important commercial alliance for PhotoCure ASA
Agreement on production on Metvix® during commercial phacePhotoCure is developing medicinal products for several types of cancer. The company is to be listed on the stock exchange within 12 months. It has now made a very important alliance with the British company Penn Pharmaceuticals concerning production of PhotoCures first product (Metvix®) during commercial phace.PhotoCure was established in 1993 for commercialisation of products within photodynamic therapy of cancer and also works to develop new products for cancer vaccines as well as products for gene therapy. The company has a